Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high‑risk region

Hedayatizadeh‑Omran,Akbar; Alizadeh‑Navaei,Reza; Janbabaei,Ghasem; Omrani‑Nava,Versa; Hasheminasab,Yahya; Amjadi,Omolbanin; Tehrani,Mohsen

doi:10.3892/br.2018.1070

Association of P53 gene polymorphism with gastric cancer in Northern Iran as a high‑risk region

Authors:
- Akbar Hedayatizadeh‑Omran
- Reza Alizadeh‑Navaei
- Ghasem Janbabaei
- Versa Omrani‑Nava
- Yahya Hasheminasab
- Omolbanin Amjadi
- Mohsen Tehrani
View Affiliations

Affiliations: Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Mazandaran 48166‑33131, Iran
Published online on: February 22, 2018 https://doi.org/10.3892/br.2018.1070
Pages: 433-438

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Gastric cancer has the fourth highest morbidity rate of all cancers worldwide. Genetic factors including alterations in oncogenes and tumor suppressor genes serve an important role in gastric cancer development and progression. The P53 gene acts as a tumor suppressor gene by regulating the cell cycle, DNA transcription and repair, apoptosis, senescence and genome stability. In addition to somatic P53 mutations in cancer development, germline polymorphisms are also involved in different malignancies. The polymorphism of P53 at codon 72 (Arg72Pro) is established as a common variant that increases susceptibility to various cancers. The present case‑control study was conducted to evaluate the possible association between this P53 polymorphism and gastric cancer in the Iranian population. A total of 59 patients with gastric cancer and 59 healthy controls were enrolled in the present study. Genomic DNA was extracted from peripheral blood mononuclear cells and genotype analysis was performed using a polymerase chain reaction‑based restriction fragment length polymorphism assay. Genotype frequencies did not differ significantly between the patients and controls (P=0.4); the frequencies of the three genotypes Arg/Arg, Arg/Pro and Pro/Pro in gastric cancer patients were 28.8, 49.2 and 22.0%, and in controls were 37.3, 49.2 and 13.6%. Additionally, there were no differences in genotype frequencies based on tumor location, histological differentiation or tumor stage. Based on these findings, it may be concluded that the P53 codon 72 polymorphism does not contribute to gastric cancer susceptibility in Northern Iran.

View Figures

View References

1	Wang C, Zhang J, Cai M, Zhu Z, Gu W, Yu Y and Zhang X: DBGC: A Database of Human Gastric Cancer. PLoS One. 10:e01425912015. View Article : Google Scholar : PubMed/NCBI
2	El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al: Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:398–402. 2000. View Article : Google Scholar : PubMed/NCBI
3	Ang TL and Fock KM: Clinical epidemiology of gastric cancer. Singapore Med J. 55:621–628. 2014. View Article : Google Scholar : PubMed/NCBI
4	Eybpoosh S, Talebkhan Y, Saberi S, Esmaeili M, Oghalaie A, Ebrahimzadeh F, Karimi T, Abdirad A, Nahvijou A, Mohagheghi MA, et al: Mohammadi M. Age-specific gastric cancer risk indicated by the combination of Helicobacter pylori sero-status and serum pepsinogen levels. Iran Biomed J. 19:133–142. 2015.PubMed/NCBI
5	Zali H, Rezaei-Tavirani M and Azodi M: Gastric cancer: Prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench. 4:175–185. 2011.PubMed/NCBI
6	Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y and Oue N: Molecular pathology of gastric cancer: Research and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
7	Arjmand Kolukhi Z, Salehi Z, Mashayekhi F, Najafi B and Mirpoor S: Analysis of Glu298Asp eNOS Gene polymorphism in patients with Gastric Cancer in the Guilan population. Analysis. 17:53–62. 2014.
8	Hossein Pour Feizi MA, Ravanbakhsh Gavgani R, Pourahmad R, Pouladi N, Azarfam P and Montazeri V: Association of p53 Arg/Pro polymorphism at codon 72 with risk of breast cancer in east azerbaijani women. J Babol Univ Med Sci. 14:31–38. 2012.
9	Buyru N, Tigli H and Dalay N: P53 codon 72 polymorphism in breast cancer. Oncol Rep. 10:711–714. 2003.PubMed/NCBI
10	Gloria-Bottini F, Banci M, Saccucci P, Neri A, Bottini E and Magrini A: p53 codon 72 polymorphism and coronary artery disease: Evidence of interaction with ACP1. Med Sci Monit. 18:CR712–CR715. 2012. View Article : Google Scholar : PubMed/NCBI
11	Lin HY, Huang CH, Wu WJ, Chang LC and Lung FW: TP53 codon 72 gene polymorphism paradox in associated with various carcinoma incidences, invasiveness and chemotherapy responses. Int J Biomed Sci. 4:248–254. 2008.PubMed/NCBI
12	Kalemi TG, Lambropoulos AF, Gueorguiev M, Chrisafi S, Papazisis KT and Kotsis A: The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett. 222:57–65. 2005. View Article : Google Scholar : PubMed/NCBI
13	Weng Y, Lu L, Yuan G, Guo J, Zhang Z, Xie X, Chen G and Zhang J: p53 codon 72 polymorphism and hematological cancer risk: An update meta-analysis. PLoS One. 7:e458202012. View Article : Google Scholar : PubMed/NCBI
14	Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W and Shao ZM: Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet. 18:2502–2517. 2009. View Article : Google Scholar : PubMed/NCBI
15	Liu Y, Zhang X, Han C, Wan G, Huang X, Ivan C, Jiang D, Rodriguez-Aguayo C, Lopez-Berestein G, Rao PH, et al: TP53 loss creates therapeutic vulnerability in colorectal cancer. Nature. 520:697–701. 2015. View Article : Google Scholar : PubMed/NCBI
16	Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, et al Swedish Low-risk Colorectal Cancer Study Group, : A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 43:1098–1103. 2011. View Article : Google Scholar : PubMed/NCBI
17	Khatami F, Noorinayer B, Ghiasi S, Mohebi R, Hashemi M and Zali MR: Single nucleotide polymorphisms of DNA methyltransferase 1 gene and gastric cancer in iranian patients: a case control study. Asian Pac J Cancer Prev. 10:1177–1182. 2009.PubMed/NCBI
18	Amoori N, Mahdavi S and Enayatrad M: Epidemiology and trend of stomach cancer mortality in Iran. Int J Epidemiol Res. 3:268–275. 2016.
19	Hedayatizadeh-Omran A, Rafiei A, Alizadeh-Navaei R, Tehrani M, Valadan R, Moradzadeh K, Panbechi M and Taghavi SM: Role of HER2 in brain metastasis of breast cancer: A systematic review and meta-analysis. Asian Pac J Cancer Prev. 16:1431–1434. 2015. View Article : Google Scholar : PubMed/NCBI
20	Hedayatizadeh-Omran A, Rafiei A, Khajavi R, Alizadeh-Navaei R, Mokhberi V and Moradzadeh K: Association between ghrelin gene (Leu72Met) polymorphism and ghrelin serum level with coronary artery diseases. DNA Cell Biol. 33:95–101. 2014. View Article : Google Scholar : PubMed/NCBI
21	Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M and Hirohashi S: p53 mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer. 54:759–764. 1993. View Article : Google Scholar : PubMed/NCBI
22	Matei MC, Negură L, Liliac L, Negură A and Azoicăi D: Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 gene's polymorphisms in relation with ovarian cancer in a Romanian population. Rom J Morphol Embryol. 53:47–54. 2012.PubMed/NCBI
23	Pandey R, Misra V, Misra SP, Dwivedi M and Misra A: Helicobacter pylori infection and a P53 codon 72 single nucleotide polymorphism: A reason for an unexplained Asian enigma. Asian Pac J Cancer Prev. 15:9171–9176. 2014. View Article : Google Scholar : PubMed/NCBI
24	Chung WC, Lee KM, Lee BI, Chun JS, Lee SY, Chang UI, Park SH, Yang JM, Choi KY and Chung IS: P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med. 21:28–32. 2006. View Article : Google Scholar : PubMed/NCBI
25	Liu X, Wang S, Xia X, Chen Y, Zhou Y, Wu X, Zhang J, He S, Tan Y, Qiang F, et al: Synergistic role between p53 and JWA: Prognostic and predictive biomarkers in gastric cancer. PLoS One. 7:e523482012. View Article : Google Scholar : PubMed/NCBI
26	Zhou Y, Li N, Zhuang W and Wu X: p53 Codon 72 polymorphism and gastric cancer risk in a Chinese Han population. Genet Test Mol Biomarkers. 14:829–833. 2010. View Article : Google Scholar : PubMed/NCBI
27	Shen H, Solari A, Wang X, Zhang Z, Xu Y, Wang L, Hu X, Guo J and Wei Q: P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep. 11:1115–1120. 2004.PubMed/NCBI
28	Zhou Y, Li N, Zhuang W, Liu GJ, Wu TX, Yao X, Du L, Wei ML and Wu XT: P53 codon 72 polymorphism and gastric cancer: A meta-analysis of the literature. Int J Cancer. 121:1481–1486. 2007. View Article : Google Scholar : PubMed/NCBI
29	Liu KJ, Qi HZ, Yao HL, Lei SL, Lei ZD, Li TG and Zhao H: An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Mol Biol Rep. 39:8265–8275. 2012. View Article : Google Scholar : PubMed/NCBI
30	Kang S, Duan LH, Zhang JH, Guo W, Wang N and Li Y: Association of p53 gene polymorphism with susceptibility to ovarian cancer. Zhonghua Fu Chan Ke Za Zhi. 39:754–758. 2004.(In Chinese). PubMed/NCBI
31	Tang NP, Wu YM, Wang B and Ma J: Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer. Eur J Surg Oncol. 36:431–438. 2010. View Article : Google Scholar : PubMed/NCBI
32	Liu Y, Qin H, Zhang Y, Shi T, Liu B, Sun Y and Ma Y: P53 codon 72 polymorphism and colorectal cancer: A meta-analysis of epidemiological studies. Hepatogastroenterology. 58:1926–1929. 2011.PubMed/NCBI
33	Jing G, Lv K and Jiao X: The p53 codon 72 polymorphism and the risk of oral cancer in a Chinese Han population. Genet Test Mol Biomarkers. 16:1149–1152. 2012. View Article : Google Scholar : PubMed/NCBI
34	Zhang R, Chen W, Zhang W, Jiang Q, Liu C, Lin Y, Hu Z, Yu S and Xu G: Genetic polymorphisms of p53 codon 72 and bladder cancer susceptibility: A hospital-based case-control study. Genet Test Mol Biomarkers. 15:337–341. 2011. View Article : Google Scholar : PubMed/NCBI
35	Suzuki K, Matsui H, Ohtake N, Nakata S, Takei T, Nakazato H, Okugi H, Koike H, Ono Y, Ito K, et al: A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese. J Biomed Sci. 10:430–435. 2003. View Article : Google Scholar : PubMed/NCBI
36	Jia S, Xu L, Chan Y, Wu X, Yang S, Yu H, Yang H, Luo Y and Tang W: p53 codon 72 polymorphism and endometriosis: A meta-analysis. Arch Gynecol Obstet. 285:1657–1661. 2012. View Article : Google Scholar : PubMed/NCBI
37	Lao X, Chen Z and Qin A: p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations. Arch Gynecol Obstet. 293:1023–1031. 2016. View Article : Google Scholar : PubMed/NCBI
38	Soleimani A, Rahmani Y, Farshchian N, Delpisheh A, Khassi K, Shahmohammadi A and Amirifard N: The evaluation of p53 polymorphism at codon 72 and association with breast cancer in Iran: A systematic review and meta-analysis. J Cancer Prev. 21:1–293. 2016. View Article : Google Scholar : PubMed/NCBI